Myriad Genetics Inc

Ownership Transactions Reported by 26 Insiders

Symbol
MYGN on Nasdaq
Location
322 North 2200 West, Salt Lake City, Utah

Insiders trading volume in the past year

Myriad Genetics Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Paul J. Diaz President and CEO, Director $26.7 M -$5.73 M -17.6% May 13, 2024
Samraat S. Raha Chief Operating Officer $6.37 M Mar 14, 2024
Mark Verratti Chief Commercial Officer $5.84 M Apr 14, 2024
Richard Bryan Riggsbee Chief Financial Officer $5.59 M -$1.04 M -15.7% Jan 29, 2024
Jerry S. Lanchbury Officer $5.06 M Jan 14, 2022
Nicole Lambert Chief Operating Officer $4.29 M Oct 31, 2023
Scott J. Leffler Chief Financial Officer $3.62 M Mar 14, 2024
S. Louise Phanstiel Director $3.54 M Jun 6, 2024
Jayne B. Hart Officer $3.3 M Mar 1, 2023
Kevin Richard Haas Chief Technology Officer $2.94 M Mar 22, 2024
Heinrich Dreismann Director $2.9 M Jun 6, 2024
Dale Muzzey Chief Scientific Officer $2.15 M Apr 14, 2024
Dennis Langer Director $2.04 M Jun 30, 2022
Margaret Ancona SVP, Chief of Staff $2.02 M Mar 22, 2024
Colleen F. Reitan Director $1.95 M Jun 6, 2024
Daniel Skovronsky Director $1.9 M Jun 6, 2024
Rashmi Kumar Director $1.87 M Jun 6, 2024
Lee Nisley Newcomer Director $1.82 M -$157 K -7.95% Jun 6, 2024
Paul Parkinson Fmr EVP Strategy & Innovation $1.67 M May 14, 2021
Heinrich Dreismann Director $1.6 M Jun 3, 2021
Pamela Wong Chief Legal Officer $1.45 M Mar 22, 2024
Shereen Solaiman Chief People Officer $1.18 M Mar 14, 2024
Eric Santa Former Chief Growth Officer $1.09 M Apr 26, 2022
Natalie Munk Chief Accounting Officer $900 K Apr 6, 2024
Paul Bisaro Director $885 K Jun 6, 2024
Daniel K. Spiegelman Director $726 K -$167 K -18.7% Jun 6, 2024

Recent Insider Transactions by Companies or Individuals for Myriad Genetics Inc

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership